
View larger version (41K):
[in a new window]
|
Fig. 5. Cingulin mutation does not influence the junctional localization of ZO-1, occludin or claudin-6, or the permeability of TJs to NHS-LC-Biotin in cystic EBs. (A-C) Immunofluorescence analysis of EBs that were fixed, sectioned and stained with antibodies against the antigens indicated above each set of images. Color coding corresponds to secondary antibodies fluorophores used (green, FITC-labeled anti-mouse antibody; red, Cy5-labeled anti-rabbit antibody), except in the case of the double cingulin-ZO-1 labeling, in which color was inverted (rabbit anti-cingulin antibody followed by Cy5-anti-rabbit antibody, and rat anti-ZO-1 antibody followed by FITC-anti-rat antibody were used). Monoclonal antibody against cingulin was used for co-localization with occludin (B). In `merge' images, the yellow color shows co-localization of proteins. Junctional cingulin labeling is not detected in homozygous (/) cystic EBs (A,B). (D) Biotin permeability assay. EBs were incubated in 1 mg ml1 NHS-LC-Biotin, washed, fixed, sectioned and stained with FITC-conjugated avidin (green) and TRITC-phalloidin (red) to visualize NHS-LC-Biotin and actin filaments, respectively. Epithelial cells with functional TJs exclude NHS-LC-Biotin from intercellular spaces, resulting in labeling being restricted to apical surfaces. `Out' and `In' in the (+/+) merge image indicate spaces outside and inside the cavity of the EBs, respectively. Scale bar, 10 µm.
|